Risk factors for thromboembolism during first-line treatment of patients with unresectable advanced or recurrent colorectal cancer: a retrospective short study

BACKGROUND: While cancer is a risk factor for developing thromboembolism, so is the use of molecularly targeted therapies. This study aimed to determine whether thromboembolism incidence differed between vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Ryo, Fujiwara, Miki, Maki, Masatoshi, Takahashi, Yoko, Tamura, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316546/
https://www.ncbi.nlm.nih.gov/pubmed/37394446
http://dx.doi.org/10.1186/s40780-023-00291-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316546/
https://www.ncbi.nlm.nih.gov/pubmed/37394446
http://dx.doi.org/10.1186/s40780-023-00291-0

Ejemplares similares